Top Market Leader – Medical Foam Market Medical Foam Market by Form (Flexible, Rigid, Spray), Material (Polymers, Latex, Metals), Application (Bedding & Cushioning, Medical Packaging, Medical Devices & Components, Prosthetics & Wound Care), and Region The global medical foam market size is estimated at USD 27.7 billion in 2020 and is projected to reach USD 37.2 billion by 2025, at a CAGR of 6.1% from 2020 to 2025. The bedding & cushioning segment was the largest application of medical foam owing to a rise in the geriatric population and an increase in health-related concerns in the aged population leading to high demand for comfort and orthopedic support. The increase in the health expenditure of several countries has led to growth in the market for medical foam. Major companies such as The Dow Chemical Company (US), SEKISUI CHEMICAL CO., LTD. (Japan), Huntsman Corporation (US), Trelleborg AB (Sweden), BASF SE (Germany), Recticel NV (Belgium), INOAC Corporation (Japan), UFP Technologies, Inc. (US), FXI Holdings, Inc. (US), Armacell International S.A. (Germany), Rogers Corporation (US), Freudenberg Group (Germany), Mölnlycke Health Care AB (Sweden), VPC Group Inc. (Canada), FoamPartner Group (Switzerland), The Woodbridge Group (Canada), General Plastics Manufacturing Company (US), and others are key players in the global medical foam market. These players have been focusing on developmental strategies, such as expansions, mergers & acquisitions, partnerships, and new product launches & developments, which have helped them expand their businesses in untapped and potential markets. They have also been adopting various organic and inorganic growth strategies, such as mergers & acquisitions, and expansions, to enhance their current positions in the medical foam market. To know about the assumptions considered for the study download the pdf brochure The Dow Chemical Company is one of the leaders in the chemical industry and a global leader in the medical foam market. The company has a global presence with several manufacturing sites and sales offices. The Dow Chemical Company offers several products of polyurethane foam for applications such as bedding & cushioning and packaging. The foams offered by the company are highly resilient and viscoelastic foams that provide high comfort. The company has a limited presence in emerging markets of the Asia Pacific region. Hence, it could adopt some growth strategies such as acquisitions or mergers with existing players in the region. This could help the company increase its market presence in this untapped region. SEKISUI CHEMICAL CO., LTD. is a Japanese firm offering various solutions such as polyethylene, urethanes, and polyurethanes for polymer consumers. The company provides medical foam under the brands Softlon and Volara, which are developed by using irradiated cross-linking technology and are nearly 100% closed-cell foam. The company operates and distributes products in North America, Europe, Central/South America, China, Japan, and Asia & Oceania. SEKISUI CHEMICAL CO., LTD. is expanding its business through inorganic growth strategies such as expansion to meet the growing demand for medical-grade foam. In November 2017, SEKISUI CHEMICAL CO., LTD. established a polyolefin foam plant in Thailand through the THAI SEKISUI FOAM CO., LTD. division of the company. The company expanded its foam production line to meet the increasing demand for foam from the construction, medical, automotive, and other sectors. With this increase in production, the company was able to produce 5-million-meters square of polyolefin foam per year.